Want to see IN:VIJAYA full AI Analyst Report?
VIJAYA Stock Chart & Stats
₹1313.00
₹36.90(2.81%)
At close: 4:00 PM EDT
₹1313.00
₹36.90(2.81%)
Day’s Range― - ―
52-Week Range₹847.90 - ₹1,440.00
Previous CloseN/A
Volume84.81K
Average Volume (3M)7.14K
Market Cap
₹138.06B
Enterprise Value₹104.05K
Total Cash (Recent Filing)₹2.81B
Total Debt (Recent Filing)₹4.23B
Price to Earnings (P/E)79.9
Beta0.69
Next Earnings
Aug 06, 2026EPS Estimate
4.51Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)16.83
Shares Outstanding102,896,730
10 Day Avg. Volume16,300
30 Day Avg. Volume7,139
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)9.51
Price to Sales (P/S)11.18
P/FCF Ratio103.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,400.00Price Target Upside6.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)21.68
Revenue Forecast (FY)₹9.67B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue & Strong MarginsSustained top-line growth with durable high margins reflects a scalable diagnostics model and pricing power. Persistent EBITDA and net margins indicate structural profitability from lab scale, hub-and-spoke efficiencies, and higher-margin imaging services, supporting reinvestment and long-term cash generation.
Healthy Balance SheetModerate leverage and growing equity provide financial flexibility for measured expansion of centres and equipment. Solid historical ROE indicates attractive capital returns, reducing refinancing pressure and enabling incremental capex without overburdening the balance sheet in normal operating conditions.
Strong Operating Cash GenerationConsistent operating cash generation above reported profits supports durable funding for working capital and capex. Reliable OCF enhances earnings quality, lowers dependence on external financing for growth, and gives management flexibility to invest in labs, equipment, and collection-network expansion.
Bears Say
Uneven Free Cash Flow ConversionVolatile FCF conversion signals sensitivity to capex timing or working-capital swings, making cash available for dividends or debt paydown less predictable. This variability can constrain strategic investments or require occasional external funding during periods of elevated capital spending or seasonally higher receivables.
Gross Margin VolatilityA sharp gross margin decline indicates exposure to cost pressures, test-mix shifts, or pricing dynamics. Even if margins rebounded, variability raises concern over input cost pass-through, supplier concentration, or pricing negotiation power with institutional customers, potentially pressuring long-term margin sustainability.
Rising Absolute DebtAn increase in absolute debt reduces cushion against downturns and raises interest and refinancing risk if growth slows. While leverage remains moderate, higher borrowings could constrain future capital allocation, especially if free cash flow conversion remains uneven or capex needs rise with network expansion.
Vijaya Diagnostic Centre Ltd. News
VIJAYA FAQ
What was Vijaya Diagnostic Centre Ltd.’s price range in the past 12 months?
Vijaya Diagnostic Centre Ltd. lowest stock price was ₹847.90 and its highest was ₹1440.00 in the past 12 months.
What is Vijaya Diagnostic Centre Ltd.’s market cap?
Vijaya Diagnostic Centre Ltd.’s market cap is ₹138.06B.
When is Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date?
Vijaya Diagnostic Centre Ltd.’s upcoming earnings report date is Aug 06, 2026 which is tomorrow.
How were Vijaya Diagnostic Centre Ltd.’s earnings last quarter?
Vijaya Diagnostic Centre Ltd. released its earnings results on May 07, 2026. The company reported ₹4.7 earnings per share for the quarter, beating the consensus estimate of ₹4.213 by ₹0.487.
Is Vijaya Diagnostic Centre Ltd. overvalued?
According to Wall Street analysts Vijaya Diagnostic Centre Ltd.’s price is currently Undervalued.
Does Vijaya Diagnostic Centre Ltd. pay dividends?
Vijaya Diagnostic Centre Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.22%. See more information on Vijaya Diagnostic Centre Ltd. dividends here
What is Vijaya Diagnostic Centre Ltd.’s EPS estimate?
Vijaya Diagnostic Centre Ltd.’s EPS estimate is 4.51.
How many shares outstanding does Vijaya Diagnostic Centre Ltd. have?
Vijaya Diagnostic Centre Ltd. has 102,896,730 shares outstanding.
What happened to Vijaya Diagnostic Centre Ltd.’s price movement after its last earnings report?
Vijaya Diagnostic Centre Ltd. reported an EPS of ₹4.7 in its last earnings report, beating expectations of ₹4.213. Following the earnings report the stock price went up 1.644%.
Which hedge fund is a major shareholder of Vijaya Diagnostic Centre Ltd.?
Currently, no hedge funds are holding shares in IN:VIJAYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
VIJAYA Stock 12 Month Forecast
Average Price Target
₹1,400.00
▲(6.63% Upside)
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Suraksha Diagnostic Ltd.
―
Thyrocare Technologies Ltd
―







